B Klaeser
Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome
Klass N, Aebersold D, Krause T, Plasswilm L, Blumstein N, Born E, Cihoric N, Schmidhalter D, Früh M, Malthaner M, Toepfer M, Klaeser B, Schmuecking M (2012). Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome.
Apr 19, 2012Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome
Apr 19, 2012SASRO 2012
Klass ND, Aebersold D, Krause T, Plasswilm Ludwig, Blumstein N, Born E, Cihoric N, Schmidhalter D, Früh Martin, Malthaner M, Toepfer Michael, Klaeser B, Schmuecking M
Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer
Klaeser B, Wiederkehr O, Köberle D, Mueller A, Bubeck B, Thürlimann B. Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer. Ann Oncol 2007; 18:1329-34.
Aug 1, 2007Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer
Aug 1, 2007Ann Oncol 2007; 18:1329-34
Klaeser B, Wiederkehr O, Köberle Dieter, Mueller A, Bubeck B, Thürlimann Beat
Increased pulmonary FDG Uptake in Bleomycin-associated pneumonitis
Rohr L, Klaeser B, Jörger M, Kluckert J, Cerny T, Gillessen Sommer S. Increased pulmonary FDG Uptake in Bleomycin-associated pneumonitis. Onkologie 2007:320-323.
Jan 1, 2007Increased pulmonary FDG Uptake in Bleomycin-associated pneumonitis
Jan 1, 2007Onkologie 2007:320-323
Rohr L., Klaeser B, Jörger Markus, Kluckert Jörg-Thomas, Cerny Thomas, Gillessen Sommer Silke
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
Jörger M, Warzinek T, Klaeser B, Kluckert J, Schmid H, Gillessen Sommer S. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004; 63:778-80.
Apr 1, 2004Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
Apr 1, 2004Urology 2004; 63:778-80
Jörger Markus, Warzinek T, Klaeser B, Kluckert J T, Schmid H-P, Gillessen Sommer Silke
Major tumor regression afrer paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
Jörger M, Warzinek T, Klaeser B, Kluckert J, Schmid H, Gillessen Sommer S. Major tumor regression afrer paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004; 63:778-780.
Apr 1, 2004Major tumor regression afrer paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
Apr 1, 2004Urology 2004; 63:778-780
Jörger Markus, Warzinek T, Klaeser B, Kluckert Jörg-Thomas, Schmid Hans-Peter, Gillessen Sommer Silke